Randomized double-blind study for the effect of highly absorption curcumin on volunteers with high levels of gamma-GTP

Randomized double-blind study for the effect of highly absorption curcumin on volunteers with high levels of gamma-GTP - Randomized double-blind study of highly absorption curcumin in volunteers with high levels of gamma-GTP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015490

Enrollment

Registered

2014-10-21

Start date

2014-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers with high or moderate level of gamma-GTP

Interventions

Highly absorption curcumin 180 mg/day for 12 weeks Highly absorption curcumin 60 mg/day for 12 weeks placebo for 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteers with gamma-GTP level from standard value to upper limit - 200(IU/L) at the time of study entry

Exclusion criteria

Exclusion criteria: 1) Cirrhosis or liver cancer 2) Occlusive jaundice or hepatic bile congestion 3) Use of antiplatelet 4) Pregnancy, nursing, or a wish of pregnancy within next 6 months 5) The person who participates in other clinical trials at the time of this study entry 6) etc

Design outcomes

Primary

Measure	Time frame
Evaluation of gamma-GTP level by blood examination	—

Secondary

Measure	Time frame
1) Evaluation of blood pressure 2) Hematological and biochemical evaluation by blood examination 3 Measurement of curcumin level in blood 4) Others, adverse events	—

Countries

Japan

Contacts

Public ContactTatsuya Morimoto

Shizuoka Prefectural General Hospital Department of Cardiovascular Clinical Pharmacology, Clinical Research Institue

morimoto@u-shizuoka-ken.ac.jp054-247-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026